1. The Drug Reimbursement Decision-Making System in Iran
Amir Ansaripour, PharmD, Carin A. Uyl-de Groot, PhD, Adri Steenhoek, PhD, PharmD, William K. Redekop, PhD 
Value in Health Regional Issues 
Volume 3, Pages (May 2014)
DOI: /j.vhri
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Overview of the drug registration process in Iran. CCCD, Council to Consider and Compilation Drugs; FDO, Food and Drug Organization; N, no; Y, yes.
Value in Health Regional Issues 2014 3, DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Overview of the drug reimbursement system in Iran (Stakeholders roles map).
Value in Health Regional Issues 2014 3, DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3
Overview of the drug reimbursement process in Iran. DBPRC, Drug Benefit Package Review Committee; SCoHI, Supreme Council of Health Insurance; N, no; Y, yes.
Value in Health Regional Issues 2014 3, DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions